DTIL
PRECISION BIOSCIENCES INC
NASDAQ · Healthcare · Biotechnology · US
$6.19
+7.28%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 19.53x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.77x
- Price / sales
- 3.79x
- Price / cash flow
- -3.29x
Enterprise value
- Enterprise value
- $111.4M
- EV / sales
- 2.47x
- EV / EBITDA
- -2.24x
- EV / EBIT
- -3.06x
- Market cap
- $170.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026